0074-2306 : Rinvoq 15 mg Oral Tablet, Extended Release
| NDC: | 0074-2306 |
| Labeler: | Abbvie Inc. |
| Product Type: | Human Prescription Drug |
| Drug Name: |  Rinvoq |
| Dosage Form: | Oral Tablet, Extended Release |
| Application #: | NDA211675 |
| Rev. Date: |
Appearance:
| Markings: | a15 |
| Shapes: |
Oval |
| Colors: |
 Purple |
| Size (mm): | 14 |
| Segments: * | 1 |
* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines. | |
NDC Package Codes:
- 0074-2306-30: 30 TABLET, EXTENDED RELEASE IN 1 BOTTLE (0074‑2306‑30)
- 0074-2306-70: 14 TABLET, EXTENDED RELEASE IN 1 BOTTLE (0074‑2306‑70)
Active Ingredients:
- Upadacitinib
Dosage Strength:
- 15 mg
Inactive Ingredients:
- Microcrystalline Cellulose
- Hypromellose, Unspecified
- Mannitol
- Tartaric Acid
- Silicon Dioxide
- Magnesium Stearate
- Polyvinyl Alcohol, Unspecified
- Polyethylene Glycol, Unspecified
- Talc
- Titanium Dioxide
- Ferrosoferric Oxide
- Ferric Oxide Red /
Pharmaceutical Classes:
- Janus Kinase Inhibitor [EPC]
- Janus Kinase Inhibitors [MoA]
Related Products:
Based on records with the same trade name.- 0074-1043 Rinvoq 45 mg Oral Tablet, Extended Release by Abbvie Inc.
- 0074-2310 Rinvoq 30 mg Oral Tablet, Extended Release by Abbvie Inc.
- 0074-2320 Rinvoq 1 mg/ml Oral Solution by Abbvie Inc.
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 0074-2282Next: 0074-2310 >
Related Discussions:
Rinvoq for rheumatoid arthritis
Hi ~ Just got the rheumatoid arthritis tap on the shoulder today. Rinvoq seems to be advertised a lot but I’d sure... 5 replies
Hi ~ Just got the rheumatoid arthritis tap on the shoulder today. Rinvoq seems to be advertised a lot but I’d sure... 5 replies
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.